Paullinia cupana Mart. var. Sorbilis protects human dopaminergic neuroblastoma SH-SY5Y cell line against rotenone-induced cytotoxicity

Human and Experimental Toxicology

Volumn 30, Issue 9, 2011, Pages 1382-1391

  De Oliveira, Diêgo Madureira ^a   Barreto, George ^b   Galeano, Pablo ^c   Romero, Juan Ignacio ^c   Holubiec, Mariana Inés ^c   Badorrey, Maria Sol ^c   Capani, Francisco ^c   Giraldez Alvarez, Lisandro Diego ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Instituto de Investigaciones Cardiologicos Dr Alberto C Taquini   (Argentina)

Author keywords

antioxidant activity; cytotoxicity; Guaran ; neuroprotection; Parkinson's disease; rotenone; SH SY5Y cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GUARANA EXTRACT; LACTATE DEHYDROGENASE; ROTENONE;

APOPTOSIS; ARTICLE; CELL LINE; CELL PROTECTION; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; GUARANA; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL DEGENERATION; NEUROBLASTOMA; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

ANTIOXIDANTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSECTICIDES; NEUROBLASTOMA; NEURONS; OXIDATIVE STRESS; PAULLINIA; PLANT EXTRACTS; ROTENONE; SEEDS;

PAULLINIA CUPANA;

EID: 80052553889     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110389837     Document Type: Article

References (58)

1. Greenamyre JT, Hastings TG. Biomedicine. Parkinson's - divergent causes convergent mechanisms. Science. 2004 ; 304: 1120-1122 (Pubitemid 38661838)
2. Cowan WM, Kandel ER. Prospects for neurology and psychiatry. The Journal of the American Medical Association. 2001 ; 285: 594-600 (Pubitemid 32656330)
3. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003 ; 39: 889-909 (Pubitemid 37130207)
4. Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurology. 2009 ; 8: 1128-1139
5. Sulzer D. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends in Neurosciences. 2007 ; 30: 244-250 (Pubitemid 46667168)
6. Chaturvedi RK, Beal MF. PPAR: a therapeutic target in Parkinson's disease. Journal of Neurochemistry. 2008 ; 106: 506-518
7. Sanyal J, Bandyopadhyay SK, Banerjee TK, Mukherjee SC, Chakraborty DP, Ray BC, et al. Plasma levels of lipid peroxides in patients with Parkinson's disease. European Review for Medical and Pharmacological Sciences. 2009 ; 13: 129-132
8. Schapira AH. Etiology and pathogenesis of Parkinson disease. Neurologic Clinics. 2009 ; 27: 583-603
9. Radad K, Rausch WD, Gille G. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochemistry International. 2006 ; 49: 379-386 (Pubitemid 44119044)
10. Chen S, Zhang X, Yang D, Du Y, Li L, Li X, et al. D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways. FEBS Letters. 2008 ; 582: 603-610
11. de Oliveria DM, Barreto G, De Andrade DV, Saraceno E, Aon-Bertolino L, Capani F, et al. Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease. Neurochemical Research. 2009 ; 34: 215-220
12. Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, Greenamyre JT. Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication The Journal of Biological Chemistry.. 2005 ; 280: 42026-42035
13. Verma R, Nehru B. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Neurochemistry International. 2009 ; 55: 369-375
14. Carlini EA. Plants and the central nervous system. Pharmacology, Biochemistry and Behavior. 2003 ; 75: 501-512 (Pubitemid 36936886)
15. Yamaguti-Sasaki E, Ito LA, Canteli VC, Ushirobira TM, Ueda-Nakamura T, Dias Filho BP, et al. Antioxidant capacity and in vitro prevention of dental plaque formation by extracts and condensed tannins of Paullinia cupana. Molecules. 2007 ; 12: 1950-1963
16. Datla KP, Zbarsky V, Rai D, Parkar S, Osakabe N, Aruoma OI, et al. Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease. Journal of the American College of Nutrition. 2007 ; 26: 341-349 (Pubitemid 47579902)
17. Wang YH, Samoylenko V, Tekwani BL, Khan IA, Miller LS, Chaurasiya ND, et al. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease. Journal of Ethnopharmacology. 2010 ; 128: 662-671
18. Baumann TW, Schulthess BH, Hänni K. Guarana (Paullinia cupana) rewards dispersers without intoxicating them by caffeine. Phytochemistry. 1995 ; 39: 1063-1070
19. Shirwaikar A, Shirwaikar A, Rajendran K, Punitha IS. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biological & Pharmaceutical Bulletin. 2006 ; 29: 1906-1910 (Pubitemid 44338416)
20. Fragoso V, do Nascimento NC, Moura DJ, Silva AC, Richter MF, Saffi J, et al. Antioxidant and antimutagenic properties of the monoterpene indole alkaloid psychollatine and the crude foliar extract of Psychotria umbellata Vell. Toxicology in Vitro. 2008 ; 22: 559-566
21. Liu Y, Ji H, Dong J, Zhang S, Lee KJ, Matthew S. Antioxidant alkaloid from the South China Sea marine sponge Iotrochota sp. Zeitschrift für Naturforschung. C. Journal of Biosciences. 2008 ; 63: 636-638
22. Nobre HV Jr, de Andrade Cunha GM, de Vasconcelos LM, Magalhães HI, Neto RN, Maia FD, et al. Caffeine and CSC adenosine A(2A) antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells. Neurochemistry International. 2010 ; 56: 51-58
23. Basile A, Ferrara L, Pezzo MD, Mele G, Sorbo S, Bassi P, et al. Antibacterial and antioxidant activities of ethanol extract from Paullinia cupana. Mart Journal of Ethnopharmacology. 2005 ; 102: 32-36 (Pubitemid 41375935)
24. da Costa Miranda V, Trufelli DC, Santos J, Campos MP, Nobuo M, da Costa Miranda M, et al. Effectiveness of guaraná (Paullinia cupana) for postradiation fatigue and depression: results of a pilot double-blind randomized study. Journal of Alternative and Complementary Medicine (New York N.Y.). 2009 ; 15: 431-433
25. Ravi Subbiah MT, Yunker R. Studies on the nature of anti-platelet aggregatory factors in the seeds of the Amazonian Herb Guarana (Paullinia cupana). International Journal for Vitamin and Nutrition Research. 2008 ; 78: 96-101
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods. 1983 ; 65: 55-63 (Pubitemid 14203433)
27. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. Journal of Immunological Methods. 1989 ; 119: 203-210 (Pubitemid 19132276)
28. Keilhoff G, Wolf G. Comparison of double fluorescence staining and LDH-test for monitoring cell viability in vitro. Neuroreport. 1993 ; 5: 129-132 (Pubitemid 23349703)
29. Valverde G, De Andrade D, Madureira de Oliveria D, Barreto G, Bertolino LA, Saraceno E, et al. Effects of the extract of Anemopaegma mirandum (Catuaba) on rotenone-induced apoptosis in human neuroblastomas SH-SY5Y cells. Brain Research. 2008 ; 1198: 188-196
30. Vanitallie TB. Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction. Metabolism: Clinical and Experimental. 2008 ; 57: 50-55
31. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009 ; 373: 2055-2066
32. Borland MK, Trimmer PA, Rubinstein JD, Keeney PM, Mohanakumar K, Liu L, et al. Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells. Molecular Neurodegeneration. 2008 ; 3: 21
33. Xiong Y, Ding H, Xu M, Gao J. Protective effects of asiatic acid on rotenone- or H2O2-induced injury in SH-SY5Y cells. Neurochemical Research. 2009 ; 34: 746-754
34. Orth M, Schapira AH.. 2002 ; 40: 533-541
35. Muqit MM, Gandhi S, Wood NW. Mitochondria in Parkinson disease: back in fashion with a little help from genetics. Archives of Neurology. 2006 ; 63: 649-654
36. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983 ; 219: 979-980 (Pubitemid 13189531)
37. Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sciences. 1985 ; 36: 2503-2508 (Pubitemid 15072756)
38. Kinemuchi H, Fowler CJ, Tipton KF. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) and its relevance to Parkinson's disease. Neurochemistry International. 1987 ; 11: 359-373 (Pubitemid 18017269)
39. Gerlach M, Riederer P, Przuntek H, Youdim MB. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. European Journal of Pharmacology. 1991 ; 208: 273-286
40. Choi WS, Kruse SE, Palmiter RD, Xia Z. Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proceedings of the National Academy of Sciences. 2008 ; 105: 15136-15141
41. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain. 1992 ; 115: 333-342
42. Menke T, Gille G, Reber F, Janetzky B, Andler W, Funk RH, et al.. 2003 ; 18: 65-72
43. Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, et al.. 2009 ; 109: 427-1439
44. Henchcliffe C, Beal MF.. 2008 ; 4: 600-609
45. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology. 1998 ; 50: 1346-1350 (Pubitemid 28240350)
46. Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson's disease - is there a link?. Environmental Health Perspectives. 2006 ; 114: 156-164 (Pubitemid 43193633)
47. Dhillon AS, Tarbutton GL, Levin JL, Plotkin GM, Lowry LK, Nalbone JT, et al.. 2008 ; 13: 37-48
48. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. The journal of Biological Chemistry. 2002 ; 278: 8516-8525
49. Kuskoski EM, Roseane F, García AA, Troncoso GAM. Propiedades químicas y farmacológicas del fruto Guaraná (Paullinia cupana). Vitae Rev Fac Quím Farm. 2005 ; 12: 45-52
50. Mattei R, Dias RF, Espínola EB, Carlini EA, Barros SB. Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidants activity in vitro. Journal of Ethnopharmacology. 1998 ; 60: 111-116 (Pubitemid 28143720)
51. Jimoh FO, Sofidiya MO, Afolayan AJ. Antioxidant properties of the methanol extracts from the leaves of Paullinia pinnata. Journal of Medicinal Food. 2007 ; 10: 707-711
52. Shi C, Fang L, Yew DT, Yao Z, Xu J. Ginkgo biloba extract EGb761 protects against mitochondrial dysfunction in platelets and hippocampi in ovariectomized rats. Platelets. 2010 ; 21: 53-59
53. Kim MS, Lee JI, Lee WY, Kim SE. Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease. Phytother Res. 2004 ; 18: 663-666
54. Costa AF. Farmacognosia. 1972 ;:
55. Fukumasu H, Avanzo JL, Heidor R, Silva TC, Atroch A, Moreno FS, et al.. 2006 ; 44: 862-867
56. Tarozzi A, Morroni F, Hrelia S, Angeloni C, Marchesi A, Cantelli-Forti G, et al.. 2007 ; 424: 36-40
57. Younes-Mhenni S, Frih-Ayed M, Kerkeni A, Bost M, Chazot G. Peripheral blood markers of oxidative stress in Parkinson's disease. European Neurology. 2007 ; 58: 78-83 (Pubitemid 47237650)
58. Hajieva P, Mocko JB, Moosmann B, Behl C. Novel imine antioxidants at low nanomolar concentrations protects dopaminergic cells from oxidative neurotoxicity. Journal of Neurochemistry. 2009 ; 110: 118-132